The extravagance of any corporate office is directly proportional to management's reluctance to reward the shareholders.

It isn't the head but the stomach that determines the fate of the stockpicker.

My high-tech aversion caused me to make fun of the typical biotech enterprise: $100 million in cash from selling shares, one hundred Ph.D.'s, 99 microscopes, and zero revenues.

There are substantial rewards for adopting a regular routine of investing and following it no matter what, and additional rewards for buying more shares when most investors are scared into selling.

The real key to making money in stocks is not to get scared out of them.

If you're prepared to invest in a company, then you ought to be able to explain why in simple language that a fifth grader could understand, and quickly enough so the fifth grader won't get bored.

In business, competition is never as healthy as total domination.